October 09, 2018 Amicus muscles in on Pompe gene therapy chase As data on Amicus Therapeutics' clinical-stage Pompe disease candidate roll in, the group locks up preclinical gene therapy assets.
July 19, 2018 The million-dollar question hanging over US research funding law As drug prices climb, is it time to ask whether the landmark technology transfer law is a fair deal for US taxpayers?
November 24, 2016 Upcoming events – Bluebird showcases its CAR-T approach while Medgenics aims for mGluR
